Total Payments
$142,314
2024 Payments
$47,630
Companies
11
Transactions
255
Medicare Patients
816
Medicare Billing
$104,066
Payment Breakdown by Category
Other$75,145 (52.8%)
Consulting$37,790 (26.6%)
Travel$22,234 (15.6%)
Food & Beverage$7,134 (5.0%)
Education$11.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $73,051 | 34 | 51.3% |
| Consulting Fee | $37,790 | 11 | 26.6% |
| Travel and Lodging | $22,234 | 80 | 15.6% |
| Food and Beverage | $7,134 | 128 | 5.0% |
| Honoraria | $2,094 | 1 | 1.5% |
| Education | $11.59 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $95,745 | 181 | $0 (2024) |
| ViiV Healthcare Company | $43,555 | 53 | $0 (2024) |
| Seqirus USA Inc | $2,109 | 2 | $0 (2024) |
| Allergan, Inc. | $522.60 | 11 | $0 (2020) |
| Shionogi Inc | $99.73 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $82.18 | 1 | $0 (2019) |
| Janssen Products, LP | $81.58 | 1 | $0 (2019) |
| PFIZER INC. | $41.45 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $39.54 | 1 | $0 (2017) |
| ABBVIE INC. | $20.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,630 | 92 | Gilead Sciences, Inc. ($28,081) |
| 2023 | $27,777 | 49 | Gilead Sciences, Inc. ($17,647) |
| 2022 | $21,908 | 20 | Gilead Sciences, Inc. ($11,264) |
| 2021 | $8,900 | 5 | ViiV Healthcare Company ($5,520) |
| 2020 | $8,919 | 23 | Gilead Sciences, Inc. ($8,804) |
| 2019 | $18,421 | 34 | Gilead Sciences, Inc. ($18,097) |
| 2018 | $8,605 | 29 | Gilead Sciences, Inc. ($8,357) |
| 2017 | $155.07 | 3 | Gilead Sciences Inc ($115.53) |
All Payment Transactions
255 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: COVID-19 | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: COVID-19 | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: COVID-19 | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Consulting Fee | Cash or cash equivalent | $3,560.00 | General |
| Category: COVID-19 | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $78.12 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: HIV | ||||||
| 12/06/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: HIV | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: HIV | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $109.18 | General |
| Category: HIV | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $66.44 | General |
| Category: HIV | ||||||
| 11/21/2024 | ViiV Healthcare Company | CABENUVA (Biological), DOVATO | Food and Beverage | In-kind items and services | $59.00 | General |
| Category: HIV | ||||||
| 11/19/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: HIV | ||||||
| 11/18/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| Category: HIV | ||||||
| 11/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $44.13 | General |
| 11/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $59.99 | General |
| Category: COVID-19 | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $59.99 | General |
| Category: COVID-19 | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $59.99 | General |
| Category: COVID-19 | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $50.83 | General |
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $471.95 | General |
| Category: COVID-19 | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Travel and Lodging | In-kind items and services | $336.59 | General |
| Category: COVID-19 | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: COVID-19 | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $1,110.43 | General |
| Category: HIV | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $491.34 | General |
| Category: HIV | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $133.00 | General |
| Category: HIV | ||||||
| 11/12/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 168 | 287 | $92,856 | $22,323 |
| 2022 | 6 | 204 | 299 | $107,303 | $25,480 |
| 2021 | 5 | 192 | 289 | $102,218 | $24,796 |
| 2020 | 6 | 252 | 367 | $120,798 | $31,468 |
Total Patients
816
Total Services
1,242
Medicare Billing
$104,066
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 50 | 138 | $36,432 | $8,909 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 44 | $18,832 | $4,285 | 22.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 26 | $15,080 | $3,674 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 47 | $14,241 | $3,452 | 24.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $4,785 | $1,166 | 24.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 21 | $3,486 | $837.08 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 58 | $24,592 | $6,037 | 24.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 99 | $23,067 | $5,568 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 66 | $19,866 | $4,681 | 23.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 32 | $20,704 | $4,651 | 22.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 33 | $11,022 | $2,623 | 23.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $8,052 | $1,919 | 23.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 40 | 40 | $26,120 | $6,299 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 36 | 66 | $22,044 | $5,578 | 25.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 87 | $20,358 | $5,113 | 25.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 60 | $18,180 | $4,113 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 28 | 36 | $15,516 | $3,693 | 23.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 40 | 42 | $27,090 | $7,109 | 26.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 47 | 81 | $26,892 | $7,089 | 26.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 55 | 106 | $24,486 | $6,401 | 26.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 67 | 91 | $21,658 | $5,708 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 33 | $11,418 | $2,803 | 24.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $9,254 | $2,357 | 25.5% |
About Dr. Tobias Pusch, M.D
Dr. Tobias Pusch, M.D is a Internal Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811189632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tobias Pusch, M.D has received a total of $142,314 in payments from pharmaceutical and medical device companies, with $47,630 received in 2024. These payments were reported across 255 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($73,051).
As a Medicare-enrolled provider, Pusch has provided services to 816 Medicare beneficiaries, totaling 1,242 services with total Medicare billing of $104,066. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Infectious Disease
- Location Portland, OR
- Active Since 08/15/2007
- Last Updated 03/24/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1811189632
Products in Payments
- Biktarvy (Drug) $64,805
- CABENUVA (Biological) $15,754
- DOVATO (Drug) $6,785
- Veklury (Drug) $5,887
- DALVANCE (Drug) $296.89
- AVYCAZ (Drug) $131.32
- TEFLARO (Drug) $114.39
- Fetroja (Drug) $99.73
- DIFICID (Drug) $82.18
- Symtuza (Drug) $81.58
- Cresemba (Drug) $39.54
- PAXLOVID (Drug) $20.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Internal Medicine $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Internal Medicine $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Internal Medicine $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Internal Medicine $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078
Internal Medicine $189,078